Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





Abbott Diagnostics Displays Alinity Family of Systems

By LabMedica International staff writers
Posted on 02 Aug 2018
Abbott Diagnostics (Abbott Park, IL, USA) displayed the Alinity next-generation family of systems at this year’s AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, Illinois, USA. More...
The Alinity harmonized family of systems across key laboratory disciplines is designed to simplify diagnostics and help deliver results that drive better patient outcomes.

Abbott's Alinity family of harmonized solutions is unprecedented in the diagnostics industry, working together to address the challenges of using multiple diagnostics platforms and simplify diagnostic testing. Alinity systems are designed to be more efficient – running more tests in less space, generating test results faster and minimizing human errors – while continuing to provide quality results.

The Alinity portfolio includes clinical chemistry, immunoassay, blood and plasma screening, point of care, hematology and molecular diagnostics, along with Abbott's AlinIQ—a first-of-its-kind, holistic suite of professional services that combines expertise with process analysis and informatics.

The Alinity ci-series combines the power of integrated clinical chemistry and immunoassay systems in unprecedented, innovative combinations to meet every laboratory's needs. The Alinity h-series solution integrates the Alinity hq with the Alinity hs slide maker and stainer module into a combined solution for hematology testing. The Alinity h-series solution is 20% faster per m2 than other currently available integrated hematology systems with a throughput of 133 complete blood counts (CBCs) per m2.

The Alinity m molecular system addresses operational complexities, such as increasing the capacity for growth, improving workflow efficiencies and reducing demand on labor. The Alinity s system for blood and plasma screening is designed to screen blood and plasma faster and more efficiently within a smaller footprint, helps blood and plasma centers improve productivity and maintain the highest levels of accuracy, without expanding the instrument footprint.

The Alinity PRO software works with all Alinity systems to fully maximize their potential and enhance operational productivity throughout the network, allowing for easier and consolidated system monitoring anytime, anywhere. And with predictive system monitoring through AlinIQ Always On, Abbott’s professional services can proactively monitor the health of these systems and help avoid unexpected downtime.


Gold Member
Hematology Analyzer
Medonic M32B
Gold Member
Hybrid Pipette
SWITCH
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: Development of targeted therapeutics and diagnostics for extrapulmonary tuberculosis at University Hospital Cologne (Photo courtesy of Michael Wodak/Uniklinik Köln)

Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis

Extrapulmonary tuberculosis (EPTB) remains difficult to diagnose and treat because it spreads beyond the lungs and lacks easily accessible biomarkers. Despite TB infecting 10 million people yearly, the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.